Press release article from our research archive:

FLT3 LIGAND STIMULATES GROWTH OF DENDRITIC CELLS

 Rare Cells, with Potential in Cancer Treatment, 
  Have Been Difficult to Study 

SEATTLE, Nov. 30 /PRNewswire/ -- A new molecule discovered and cloned by Immunex Corporation (Nasdaq: IMNX) may provide the basis for a significant advance in immunology. The molecule, Flt3 ligand (Flt3-L), has been shown to promote the growth of dendritic cells, a formerly elusive type of cell which plays a key role in initiating immune responses to cancer, HIV and other infectious diseases. Until now, research into the utility of dendritic cells has been hampered because these cells occur so rarely in the body.

Two papers to be presented at the American Society ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!